Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Prospective Study

ArticleAçık Erişim

Özet

Background: Overactive bladder (OAB) is an issue in the field of urology that is known for causing symptoms like urges to urinate frequently during the day and even at night (known as nocturia). Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) play a vital role in the growth and operation of nerve cells in the body. New studies are indicating a connection between these neurotrophins and OAB; As such this research project was undertaken to explore how levels of NGT and BDNF in urine might be related to the presence of OAB in individuals. Methods: This investigation employed a case-control design, enrolling 44 individuals with a confirmed diagnosis of OAB and an equal number of healthy participants as the control group. Urine samples were collected from all participants, and levels of NGF and BDNF were quantified. To account for fluctuations in urine concentration, NGF/creatinine (Cr) and BDNF/Cr ratios were also determined. Results: Our research findings revealed that individuals experiencing bladder (OAB) showed increased urinary NGF levels (statistically significant, at p < 0.001). This disparity remained consistent after adjusting for creatinine levels; There were higher NGF/Cr (statistically significant, at p = 0.001) and BDNF/Cr (statistically significant, at p < 0.001) ratios in the OAB group compared to the control group. Additionally we noted a relationship between urine NGF/Cr levels and the presence of OAB (statistically significant, at p < 0.001; Correlation coefficient: +0.686). Urine BDNF/Cr levels showed a correlation with OAB (correlation coefficient of +0.461; p value < 0.001). In OAB prediction, the NGF/Cr cutoff value was found to be 0.87, the NGF cutoff value was 180.02 pg/mL, and the BDNF/Cr ratio was 0.19. Conclusions: Elevated urinary NGF and BDNF levels are associated with OAB, suggesting a potential role for these neurotrophic factors in the pathogenesis of the condition. Further research is warranted to explore their potential as diagnostic or prognostic biomarkers and to elucidate the underlying molecular mechanisms. © 2024 The Author(s).

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11186Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorEkici, Ozgur
dc.contributor.authorGunay, Murat
dc.contributor.authorGul, Abdullah
dc.contributor.authorAdmıs, Ozlem
dc.contributor.authorBozkurt, Ali Seydi
dc.contributor.authorKeskin, Ercument
dc.date.accessioned2026-10-18T20:26:16.626290787Z
dc.date.available2026-10-18T20:26:16.626290787Z
dc.date.issued2024
dc.description.abstractBackground: Overactive bladder (OAB) is an issue in the field of urology that is known for causing symptoms like urges to urinate frequently during the day and even at night (known as nocturia). Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) play a vital role in the growth and operation of nerve cells in the body. New studies are indicating a connection between these neurotrophins and OAB; As such this research project was undertaken to explore how levels of NGT and BDNF in urine might be related to the presence of OAB in individuals. Methods: This investigation employed a case-control design, enrolling 44 individuals with a confirmed diagnosis of OAB and an equal number of healthy participants as the control group. Urine samples were collected from all participants, and levels of NGF and BDNF were quantified. To account for fluctuations in urine concentration, NGF/creatinine (Cr) and BDNF/Cr ratios were also determined. Results: Our research findings revealed that individuals experiencing bladder (OAB) showed increased urinary NGF levels (statistically significant, at p < 0.001). This disparity remained consistent after adjusting for creatinine levels; There were higher NGF/Cr (statistically significant, at p = 0.001) and BDNF/Cr (statistically significant, at p < 0.001) ratios in the OAB group compared to the control group. Additionally we noted a relationship between urine NGF/Cr levels and the presence of OAB (statistically significant, at p < 0.001; Correlation coefficient: +0.686). Urine BDNF/Cr levels showed a correlation with OAB (correlation coefficient of +0.461; p value < 0.001). In OAB prediction, the NGF/Cr cutoff value was found to be 0.87, the NGF cutoff value was 180.02 pg/mL, and the BDNF/Cr ratio was 0.19. Conclusions: Elevated urinary NGF and BDNF levels are associated with OAB, suggesting a potential role for these neurotrophic factors in the pathogenesis of the condition. Further research is warranted to explore their potential as diagnostic or prognostic biomarkers and to elucidate the underlying molecular mechanisms. © 2024 The Author(s).
dc.identifier.doi10.56434/j.arch.esp.urol.20247709.138
dc.identifier.eissn1576-8260
dc.identifier.endpage977
dc.identifier.issn0004-0614
dc.identifier.issue9
dc.identifier.pmid39632518
dc.identifier.scopus2-s2.0-85210957700
dc.identifier.startpage971
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11186
dc.identifier.volume77
dc.identifier.wosWOS:001428169700001
dc.language.isoen
dc.publisherIniestares, S.A.
dc.relation.ispartofArchivos Espanoles de Urologia
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectbrain-derived neurotrophic factor
dc.subjectnerve growth factor
dc.subjectneurotrophic factors
dc.subjectoveractive bladder
dc.subjectAdult
dc.subjectBiomarkers
dc.subjectCase-Control Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectNerve Growth Factors
dc.subjectProspective Studies
dc.subjectUrinary Bladder, Overactive
dc.subjectBDNF protein, human
dc.subjectbiological marker
dc.subjectbrain derived neurotrophic factor
dc.subjectcase control study
dc.subjectdiagnosis
dc.subjecthuman
dc.subjectprospective study
dc.subjecturine
dc.titleUrinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Prospective Study
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.wos1
rdl.departmentDepartment of Biochemistry, Erzincan Binali Yıldırım University, 24002 Erzincan, Turkey. | Department of Urology, Erzincan Binali Yıldırım University, 24002 Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)